Hikma And Richter Partner On Cariprazine In MENA Markets

Hikma and Richter enter into an agreement to supply and commercialise cariprazine, an antipsychotic treatment for patients suffering from schizophrenia, in 14 MENA markets.

Middle_East_Map
Hikma and Richter target MENA markets for their antipsychotic treatment for schizophrenic patients • Source: Shutterstock

More from Deals

More from Business